CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
- Resource Type
- Article
- Authors
- Leighl, Natasha B.; Laurie, Scott A.; Goss, Glenwood D.; Hughes, Brett G.M.; Stockler, Martin; Tsao, Ming-Sound; Hwang, David M.; Joubert, Phillipe; Kulkarni, Swati; Blais, Normand; Joy, Anil A.; Mates, Mihaela; Rana, Punam; Yadav, Sunil K.; Underhill, Craig; Lee, Christopher; Bradbury, Penelope A.; Hiltz, Andrea; Dancey, Janet; Ding, Keyue; Vera-Badillo, Francisco
- Source
- In Journal of Thoracic Oncology March 2022 17(3):434-445
- Subject
- Language
- ISSN
- 1556-0864